Skip to main content

Best Performing Stocks Year-to-Date

100 stocks · Updated Sep 20, 2026

Year-to-date performance leaders reflect the stocks generating the most price appreciation since January 1st of the current year. Leading performers include companies reporting earnings beats, receiving regulatory approvals, executing strategic pivots, or simply benefiting from sector momentum. YTD leaders are a useful starting point for momentum research, though historical outperformance does not guarantee future returns and many YTD leaders mean-revert by year end.

StockPriceYTDMarket Cap
AKTSAktis Oncology, Inc.$22.38+60061.30%$1.21B
BKNGBooking Holdings Inc.$168.41+1865.45%$132.13B
LIFEEthos Technologies Inc.$36.38+1814.47%$2.45B
SNDKSandisk Corporation$1735.49+631.10%$239.07B
ABTCAmerican Bitcoin Corp$10.28+504.70%$593.5M
ROMARoma Green Finance Limited Ordinary Shares$9.37+454.44%$562.3M
MRNAModerna, Inc.$154.18+422.82%$57.13B
TWSTTwist Bioscience Corporation$163.61+415.79%$7.92B
AGLAgilon Health, Inc.$87.27+406.76%$1.54B
TXG10x Genomics, Inc.$76.68+370.14%$9.44B
MXLMaxLinear, Inc.$80.47+361.68%$6.76B
AEHRAehr Test Systems$92.23+356.83%$2.72B
DELLDell Technologies Inc.$570.62+353.30%$391.02B
AXTIAXT, Inc.$70.53+331.35%$2.90B
IBRXImmunityBio, Inc.$8.47+327.65%$8.28B
ERASErasca, Inc.$14.96+302.15%$5.51B
PURRHyperliquid Strategies Inc Common Stock$14.00+293.26%$1.48B
PLSEPulse Biosciences, Inc.$53.65+290.75%$3.82B
RXTRackspace Technology, Inc.$3.79+290.36%$794.7M
QMCOQuantum Corporation$24.98+287.29%$938.3M
IOVAIovance Biotherapeutics, Inc.$10.20+273.44%$4.41B
ABCLAbCellera Biologics Inc.$12.62+269.01%$3.48B
CLYMClimb Bio, Inc.$14.24+256.00%$856.1M
MUMicron Technology, Inc.$1007.77+253.10%$1.10T
ATEXAnterix Inc.$76.91+252.31%$1.48B
ETONEton Pharmaceuticals, Inc.$55.78+229.86%$1.56B
MQMarqeta, Inc.$15.63+228.95%$1.62B
ELVNEnliven Therapeutics, Inc.$49.76+223.12%$3.88B
BANDBandwidth Inc.$49.91+223.01%$1.57B
DDDuPont de Nemours, Inc.$129.10+221.15%$17.14B
CORTCorcept Therapeutics Incorporated$110.95+218.82%$12.19B
ORKAOruka Therapeutics, Inc.$94.98+213.35%$5.57B
UMCUnited Microelectronics Corporation$24.53+212.09%$24.27B
STXSeagate Technology Holdings plc$857.15+211.25%$180.09B
BEBloom Energy Corporation$268.57+209.09%$82.69B
MAASMaase Inc.$16.61+207.50%$6.88B
DRTSAlpha Tau Medical Ltd$15.15+206.06%$1.30B
KOSKosmos Energy Ltd.$2.75+203.62%$1.39B
SLSSELLAS Life Sciences Group, Inc.$11.35+201.06%$2.14B
AAOIApplied Optoelectronics, Inc.$104.11+198.65%$8.45B
NVCTNuvectis Pharma, Inc.$22.52+198.28%$636.6M
CLMTCalumet Inc.$59.10+197.43%$5.02B
ICHRIchor Holdings, Ltd.$54.35+194.90%$1.79B
INTCIntel Corp.$108.29+193.47%$548.79B
SIMOSilicon Motion Technology Corporation$267.83+188.93%$4.08B
DFTXDefinium Therapeutics, Inc.$38.41+186.86%$5.16B
CDNACareDx, Inc$53.99+186.57%$2.77B
BLZEBackblaze, Inc.$13.22+183.77%$738.8M
PBFPBF Energy Inc.$76.66+182.67%$9.28B
MRVLMarvell Technology, Inc.$238.93+181.16%$210.85B
Showing 1-50 of 100 stocks

Get Your Daily Market Recap

TickFlow Daily delivers the top gainers, losers, and signals to your inbox every day at market close. Free.

Frequently Asked Questions

Is YTD performance a good predictor of future returns?

Momentum research shows short-term (1-12 month) performance does have some predictive value over the following 1-6 months. However, many YTD leaders experience mean reversion. Past YTD performance is a useful screening input, not a buy signal on its own.

What typically drives the top YTD performers?

Earnings beats, product launches, M&A activity, regulatory approvals (especially in healthcare and cannabis), short squeezes, sector rotations, and macro tailwinds are the most common catalysts for outperformance in any given year.

Should I buy YTD leaders to follow momentum?

Momentum strategies can work but require strict rules around position sizing and exit triggers. Chasing YTD leaders without understanding the fundamental catalyst often means buying after the easy gain is already captured.

How does this list change over time?

This list resets at January 1 each year. Early in the year, even small gains land stocks on the list. By year-end, the list reflects the genuine full-year outperformers. The composition changes significantly as the year progresses.

Related Stock Lists